There was no correlation between the other demographic and clinicopathological parameters (age, depth of myometrial invasion, hyperplasia, myomas, lymph node metastasis) and GLUT1 or GLUT3 expression. This evidence concerns the gene SLC2A3 and metastatic malignant neoplasm in the lymph nodes.